PTSD News

Since the launch of the 988 Suicide & Crisis Lifeline in 2022, counselors have answered more than 10 million calls, texts and chats from people seeking help for suicidal thoughts and mental health crises, according to HHS officials.

The FDA has accepted a supplemental new drug application from Otsuka and Lundbeck for Rexulti in combination with sertraline to treat adults with PTSD.

Significant dose-response associations were found for transcranial magnetic stimulation and transcranial direct current stimulation across several mental disorders, including schizophrenia and depression, according to research.

Clearmind Medicine, a clinical-stage biotech company, has attained exclusive global rights to develop, produce and commercialize compounds designed to treat PTSD and other mental health conditions, according to a press release.

United States Surgeon General Vivek H. Murthy, MD, MBA, declared firearm violence a public health crisis in the United States and called for more strategies to prevent firearm-related injuries and deaths.

At 2 months postpartum, about one in 11 women with cesarean deliveries at 34 weeks’ gestation or longer developed PTSD symptoms, according to study results published in the American Journal of Obstetrics and Gynecology.

Ten states have joined the Certified Community Behavioral Health Clinic Medicaid Demonstration Program, according to a release from HHS.

Veterans who were paired with service dogs demonstrated lower PTSD symptom severity, anxiety and depression, a study published in JAMA Network Open showed.

NEW YORK — Access to reproductive health care is a significant issue for many women in the military and women veterans, Elspeth Cameron Ritchie, MD, MPH, told Healio at the American Psychiatric Association Annual Meeting.

An FDA advisory committee voted against recommending a psychedelic treatment for PTSD, citing insufficient data for what many described as a still-promising path forward.